Primary record
(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- 库存
- 1,578 克
- 纯度
- 99.2 %
- CAS
- 474-60-2
化合物标识与属性
- CAS
- 474-60-2
- PubChem CID
- 119394
- SMILES
- C[C@H](CC[C@@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C
- Canonical SMILES
- CC(C)[C@H](C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
名称与同义词
- Campestanol
- Ergostanol
- Chalinastanol
- Epiergostanol
- Dihydrocampesterin
- 5alpha-Campestanol
- 5alpha-campestan-3beta-ol
- 474-60-2
- Plant Sterols/Stanols
- campestan-3|A-ol
- 5alpha-Dihydrocampesterol
- 24beta-Ethylcholestanol
- 24b-Ethylcholestanol
- 24beta-Methyl cholestanol
- AC1L3OQK
- RefChem:123131
- 5alpha-Ergostan-3beta-ol
- 5 alpha (H)-Campestanol
- UNII-5J08LF99N1
- 5alpga-Ergostan-3-beta-ol
- 5alpha-Ergostan-3-beta-ol
- (24R)-5alpha-ergostan-3beta-ol
- 5J08LF99N1
- DTXSID3040988
- CHEBI:36799
- Ergostan-3-ol, (3.beta.,5.alpha.,24R)-
- SCHEMBL167154
- C28H50O
- ARYTXMNEANMLMU-ATEDBJNTSA-N
- orb1705170
- (3beta,5alpha)-Ergostan-3-ol
- 5.alpha.-Ergostan-3.beta.-ol
- CTK1D7265
- NEOSPONGOSTEROL, DIHYDRO-
- (3b,5a,24R)-Ergostan-3-ol
- Ergostan-3-ol, (3beta,5alpha,24R)-
- DTXCID301436322
- GLXC-14904
- 24.BETA.-METHYLCHOLESTANOL
- 5.ALPHA.-DIHYDROCAMPESTEROL
- ZINC5761341
- 5a-Cholestan-24(RS)-methyl-3b-ol
- AR-1I1663
- C28-H50-O
- CID119394
- Ergostan-3-ol, (3b,5a,24R)-
- LMST01030103
- MFCD00201592
- MSK000521
- (3.beta.,5.alpha.)-Ergostan-3-ol
- AKOS040744794
- AN-5347
- FC19642
- 5|A-Cholestan-24(RS)-methyl-3|A-ol
- Ergostan-3-ol, (3.beta.,5.alpha.)-
- 24alpha-Methyl-5alpha-cholestan-3beta-ol
- DA-62021
- HY-113288
- J166.111F
- CS-0059519
- FT-0664212
- NS00077009
- (24R)-24-methyl-5alpha-cholestan-3beta-ol
- 24 alpha-methyl-5 alpha-cholestan-3 beta-ol
- 24S-Methyl-5-.alpha.-cholestan-3-.beta.-ol
- 5.ALPHA.-ERGOSTAN-3.BETA.-OL, (24R)-
- (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- Q15410858
- (3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(1R,4R)-1,4,5-trimethylhexyl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- (1R,3aS,3bR,5aS,7S,9aS,9bS,11aR)-1-[(2R,5R)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7-ol
- (3S,5S,8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-3-ol
- (3S,5S,8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-dimethylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-ol
- 50466-20-1
- 6538-02-9